NANOTECHNOLOGY-DRIVEN THERAPEUTICS FOR LIVER CANCER: CLINICAL APPLICATIONS AND PHARMACEUTICAL INSIGHTS

Asian Journal of Pharmaceutical and Clinical Research, Journal Year: 2025, Volume and Issue: unknown, P. 8 - 26

Published: Feb. 7, 2025

Hepatocellular carcinoma (HCC) represents a significant threat to global health and is responsible for mortality rates worldwide. Conventional treatment options such as surgery chemotherapy have inherent limitations. In order remedy these deficits, the development of novel therapeutic strategies essential. Nanomedicines shown promise in HCC they offer improved stability, controlled release, increased drug loading capacity. This review explores application nanoconstructs treatment, including active passive targeting strategies. addition, liver cell approaches, moieties, conjugation chemistry surface functionalization are investigated. A compact overview various approaches also given.

Language: Английский

Targeted therapeutic strategies for the kidney

Expert Opinion on Therapeutic Targets, Journal Year: 2024, Volume and Issue: unknown, P. 1 - 11

Published: Nov. 3, 2024

Introduction Kidney diseases impose a significant burden with high incidence and mortality rates. Current treatment options for kidney are limited, necessitating urgent development of novel effective therapeutic strategies to delay or reverse disease progression. Targeted therapies the hold promise in significantly enhancing outcomes, offering hope patients afflicted renal disorders.

Language: Английский